Clinical Trials Directory

Trials / Completed

CompletedNCT06535165

Effect of Red Beetroot Juice Intake in Adults With Long COVID-19

Effect of 14-day Red Beetroot Juice Intake on Physical Function, Gut Microbiota Composition, and Systemic Inflammation in Adults With Long COVID-19

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Catholic University of the Sacred Heart · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Red beetroot juice may have positive effects on multiple pathways involved in long COVID. The aim of this pilot study was to explore the impact of beetroot juice supplementation on physical function, gut microbiota, and systemic inflammation in adults with long-COVID

Detailed description

A single-center, double-blind, placebo-controlled randomized trial to test the effects of 14 days of beetroot juice supplementation on functional and biological outcomes in adults with long-COVID. Participants were randomized 1:1 to receive either daily oral supplementation with 200 mL beetroot juice or placebo for 14 days. The primary endpoint was the change from baseline to day 14 in the fatigue resistance test. Secondary outcomes included the distance walked on the 6-min walk test, handgrip strength, and flow-mediated dilation. Secondary endpoints also included changes from baseline in circulating inflammatory mediators, metagenomic and fecal water metabolomic profiles. Partial least squares discriminant analysis (PLS-DA) models were built to evaluate the differences in biological variables associated with the interventions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRed Beetroot Juice200ml/d for 14 days
OTHERPlacebo200ml/d for 14 days

Timeline

Start date
2021-03-01
Primary completion
2021-07-31
Completion
2021-07-31
First posted
2024-08-02
Last updated
2024-08-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06535165. Inclusion in this directory is not an endorsement.